Latest News & Updates
Breaking News
57 minutes ago
Simantini Singh Deo
Other trending news you may like to read
Zenas BioPharma Partner InnoCare Achieves Phase 2b Success For Orelabrutinib In Lupus, Wins Approval To Start Phase 3 Trial In China
Orelabrutinib meets Phase 2b primary endpoint in SLE, as InnoCare secures China approval to begin Phase 3 registrational trials.
Simantini Singh Deo
Fortress Biotech And Cyprium Therapeutics Secure FDA Acceptance Of CUTX-101 NDA Resubmission For Menkes Disease
FDA accepts resubmitted NDA for CUTX-101 to treat pediatric Menkes disease, setting a new PDUFA action date of January 14, 2026.
Simantini Singh Deo
BrandManthan 2025 Brings India’s Pharma Marketing Leaders Together for a High-Impact Strategy Summit in Mumbai
BrandManthan 2025 returns to Mumbai on December 20, bringing pharma marketing leaders together to build compliant, patient-centric brands.
Team Pharma Now
DISCO Pharmaceuticals Appoints Mark Manfredi, Ph.D., As CEO And Completes €36 Million Seed Financing To Advance Surfaceome-Targeted Cancer Pipeline
DISCO Pharmaceuticals appoints Mark Manfredi as CEO and secures €36M seed funding to advance its surfaceome-targeted ADC pipeline in SCLC and MSS-CRC.
Simantini Singh Deo
